Intellectual Property Rights, Naturally Derived Bioactive Compounds and Resource Conservation
Edited by D.D. / Rivier, L. Soejarto
Published on 18. June 1997
Book
Hardback
336 pages
978-0-444-82480-6 (ISBN)
Description
The tropical rain forests have become an important focus in the search for new drugs from natural sources, especially from plants. This volume aims to promote a better understanding between scientists and institutions located in the developed and developing countries, in their efforts to search for new medicinal agents from the plants of these forests. The papers have been contributed by scientists and researchers from both developed and developing countries worldwide, and cover issues relevant to biodiversity prospecting activities. Such issues include rules and regulations on the collection of genetic materials for biological testing; logistical and technical challenges to be faced; sharing the benefits of discovery; patent protection for the discovery of potentially useful drug candidates; intellectual property rights; and indigenous property rights. The volume will be invaluable in achieving more fruitful collaborative efforts between scientists from different countries and different institutional affiliations, in their search for new drugs from tropical forest plants.
More details
Language
English
Place of publication
Oxford
United Kingdom
Publishing group
Elsevier Science & Technology
Target group
Professional and scholarly
Illustrations
indexes
ISBN-13
978-0-444-82480-6 (9780444824806)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Content
Preface. Acknowledgements. Biodiversity prospecting and benefit-sharing: perspectives from the field (D.D. Soejarto). The position of intellectual property rights in drug discovery and development from natural products (M.R. Boyd). Natural products research: perspectives from a major pharmaceutical company (R.P. Borris). Natural product source material use in the pharmaceutical industry: the Glaxo experience (D.M. Turner). Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: creating reciprocity and maintaining relationships (S.R. King, T.J. Carlson, K. Moran). Academic Research: policies and practice (S.L. Bertha). Gene co-ops and the biotrade: translating genetic resource rights into sustainable development (W.V. Reid). Legal issues in sharing the benefits of biodiversity prospecting (T.D. Mays, K.D. Mazan). Medicinal plant genetic resources and international cooperation: the Brazilian perspective (E. Elisabetsky, L. Costa-Campos). Rules and regulations on the collection in Cameroon of biological materials for biological testing and drug discovery (J.G. Jato et al.). Juridical and sociocultural problems on the definition of a law concerning property, usage and access to genetic resources in Colombia (R. Calle). Politica de manejo y utilizacion de los recursos floristicos en la Republica Dominicana (R. Garcia, C. Roersch). Collection of biological materials in biodiversity prospecting in India: problems and solutions (B.H. Mehrotra). Ley Forestal de conservacion de areas naturales y de vida silvestre (V. Villacres, M. Suarez, V. Tafur). Rules and regulations of the Government of Vietnam on collection and exportation of biological materials (M.V. Tri, T.C. Khanh). Derechos de propiedad intelectual en Costa Rica a la luz del Convenio sobre Diversidad Biologica (R. Salazar, J.A. Cabrera). Research, valorization and exploitation of biological resources for medicinal purposes in the Malagasy Republic Madagascar (F. Randimbivololona). Interests and policies of the state of Sarawak, Malayasia regarding intellectual property rights for plant derived drugs (F.J. Chung). Guidelines and policies on collection of biological specimens in the Philippines (D.A. Madulid). Biodiversity prospecting in Nigeria: seeking equity and reciprocity in intellectual property rights through partnership arrangements and capacity building (M.M. Iwu). Tanzania's policy on biodiversity prospecting and drug discovery programs (R.L.A. Mahunnah, K.E. Mshigeni). Australian deliberations on access to its terrestrial and marine biodiversity (J.T. Baker, J.D. Bell, P.T. Murphy). Camptothecin and taxol: from discovery to clinic (M.E. Wall, M.C. Wani). Discussions. Biographical sketch of speakers. Appendices. Symposium Program. List of participants. Author index. Subject index.